(PharmaNewsWire.Com, September 13, 2019 ) Market Overview: Predictive diagnostics are genetic tests that can determine a person’s susceptibility to certain diseases. Predictive diagnostics consists of identifying the presence or inheritance of any mutated gene different from other members of the family. These tests help in the identification of genetic disorders in an individual that show no features of the disorder. The development of new diagnostic biomarkers for different diseases are targeting the prevention of common human pathologies.
Market Dynamics: The market is driven by a rise in prevalence of chronic denerative diseases such as cardiovascular, autoimmune, and neurodegenerative diseases and increase in various types of cancer especially breast cancer, need for detection of various genetic disorders at the earliest stage possible. Less reliability of biomarkers for identification of chronic degenerative diseases and lack of expertise in predictive diagnostics testing are going to restrain the market in the forecast period.
Market Segmentation: By Type • Presymptomatic • Predispositional
Geographical Analysis: By Geography, the market is segmented into: • North America • Europe • South America • Asia Pacific • The Middle East and Africa
About Us: DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
